Related Experiment Video
Updated: Feb 21, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Novel EWSR1::TEAD3 Fusion in an Adolescent With a Highly Aggressive Peritoneal Mesothelioma
Qixing Gong1, Jia Wei2, Sheng Xiao3,4
1Department of Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Abstract:
Malignant peritoneal mesothelioma (MPM) is an exceptionally rare entity in children and adolescents, exhibiting distinct clinicopathological features compared to its adult counterpart. Unlike adult cases, it typically occurs without a history of asbestos exposure or BAP1 inactivation. Although several driver gene fusions have been documented, the primary oncogenic triggers and molecular pathways involved remain largely undefined. Herein, we present an 18-year-old male who presented with ascites and abdominal distension. Computed tomography imaging revealed diffuse thickening of the peritoneum, including the omentum and mesentery. Histopathological examination showed a neoplasm composed of a mixture of atypical epithelioid and spindled cells infiltrating the adipose tissue. Immunohistochemically, the tumor cells were positive for cytokeratin, calretinin, CK5/6, and D2-40, and negative for CK20, MOC-31, and Ber-EP4, supporting the diagnosis of a biphasic mesothelioma. Molecular genetic studies identified a novel EWSR1::TEAD3 gene fusion. This is the first reported case of a peritoneal mesothelioma harboring this fusion.
Insights
Pediatric malignant peritoneal mesothelioma is rare and lacks asbestos links. This report details an 18-year-old male with a novel EWSR1::TEAD3 gene fusion, advancing understanding of this rare cancer.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- Malignant peritoneal mesothelioma (MPM) is rare in pediatric patients, differing from adult cases by lacking asbestos exposure history or BAP1 mutations.
- The oncogenic drivers and molecular pathways in pediatric MPM remain largely unknown, despite identified gene fusions.
Purpose of the Study:
- To report a unique case of MPM in an adolescent.
- To identify the molecular underpinnings of this rare pediatric malignancy.
Main Methods:
- Clinical presentation and imaging (CT scan) were analyzed.
- Histopathological and immunohistochemical analyses were performed.
- Molecular genetic studies identified a novel gene fusion.
Main Results:
- An 18-year-old male presented with ascites and abdominal distension.
- Histopathology confirmed biphasic mesothelioma.
- A novel EWSR1::TEAD3 gene fusion was identified in the tumor.
Conclusions:
- This is the first reported case of peritoneal mesothelioma with an EWSR1::TEAD3 gene fusion.
- The findings contribute to understanding the molecular landscape of pediatric MPM.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

